Can repeated or prolonged bile-duct obstruction lead to chronic inflammation and fibrotic remodeling that makes narrowing recur?

Bile-duct obstruction can initiate a self-perpetuating cholestatic injury response. For an older adult with recurrent or persistent biliary narrowing, this mechanism is clinically relevant, but recurrent stricturing still requires evaluation for its underlying cause rather than attribution to scarring alone.

Mechanistic and remodeling evidence

• Prolonged extrahepatic obstruction produces cholestasis and increased biliary pressure, followed by cholangiocyte proliferation within days in common-bile-duct-ligation models.
• This epithelial injury response is accompanied by portal/periductal inflammation and activation of myofibroblasts. Collagen deposition is evident at approximately 1 week, periportal fibrosis at 10–14 days, and substantial extracellular-matrix deposition with bridging fibrosis by roughly 3–4 weeks of sustained obstruction.
• The resulting ductular reaction, altered architecture, periductal collagen accumulation, and matrix stiffening provide a biologically coherent route from obstruction to fibrotic remodeling. Inflammation and fibrosis may be partly separable: cholangiocyte αvβ6-integrin targeting reduced fibrosis in one mechanistic study without reducing inflammation.

Recurrent narrowing

• Fibrotic remodeling can plausibly predispose to renewed narrowing: concentric periductal scarring and a stiff collagen-rich matrix can reduce luminal caliber, impair epithelial repair, and worsen cholestatic injury.
• This mechanism is most firmly established experimentally. Clinically, recurrent benign biliary strictures occur, but recurrence can also reflect the original disease, duct anatomy, incomplete drainage, prior instrumentation, infection, or occult malignancy.

Clinical implications

• A recurrent or persistent stricture should not be presumed benign or fibrosis-driven. MRI/MRCP can define anatomy and obstruction; ERCP brushings with fluoroscopy-guided biopsies, cholangioscopy-guided biopsy, or EUS may be appropriate when initial sampling is nondiagnostic or suspicion persists.

Bottom line

• Repeated or prolonged obstruction is well supported as a driver of cholestasis and progressive fibrotic biliary/portal remodeling; chronic duct-localized inflammation and fibrosis-driven recurrent narrowing are biologically plausible, moderately supported extensions of this pathway.